Newly Diagnosed With Thyroid Cancer: First Steps

"Thyroid cancer" is not one illness. The National Cancer Institute names four main types, and they behave so differently that reading about the wrong one will mislead you badly.

• Papillary thyroid cancer is by far the most common. It usually grows slowly.
• Follicular thyroid cancer is the next most common and also tends to grow slowly.
• Medullary thyroid cancer starts in different cells and can run in families.
• Anaplastic thyroid cancer is rare, grows fast, and is handled with real urgency.

Before you read anything else, find out which one is on your pathology report. Pathology is the study of the tissue that was sampled. If nobody has told you the type yet, that is a fair thing to ring and ask for today.

Most thyroid cancer gives you time. A small number of situations do not.

Call 911 or go to an emergency room straight away if you have trouble breathing, noisy or whistling breathing, a feeling that your airway is closing, or you cannot swallow your own saliva. A tumor pressing on the windpipe can shut it quickly, and this is not something to phone a clinic about and wait.

Ring your team the same day, and ask to be seen, if you have:

• A neck lump that is clearly growing over days or weeks rather than months.
• New trouble swallowing, or food sticking.
• A voice that has gone hoarse or weak and is not coming back.

These can mean a tumor is pressing on the windpipe, the food pipe, or the nerve that runs to the voice box. A fast-growing neck mass is also how anaplastic thyroid cancer often shows itself, and that type is treated as an emergency rather than a scheduled problem. Do not sit on these symptoms waiting for a booked appointment.

Staging uses the AJCC TNM system, where T is the tumor, N is the lymph nodes, and M is spread to other parts of the body. Thyroid cancer then does something no other common cancer does. For papillary and follicular thyroid cancer, your age at diagnosis changes the stage itself. The NCI describes one set of stage definitions for people younger than 55 and a different set for people 55 years and older.

This confuses people, and it is worth understanding, because it is not a clerical quirk. It reflects decades of evidence that these cancers behave differently in younger people. It also means a stage number here does not mean what it means in other cancers. Do not compare your stage with a friend's breast or bowel cancer stage. They are not the same scale.

Anaplastic thyroid cancer is staged differently again. The NCI states it plainly: "Anaplastic thyroid cancer is considered stage IV thyroid cancer." That is true even when it looks small, and it reflects how the disease behaves rather than how far it has travelled.

The NCI names the usual work-up: a physical exam, blood hormone studies, an ultrasound exam, a fine-needle aspiration biopsy of the thyroid, and sometimes a CT scan and a laryngoscopy.

A few of those deserve translating.

• An ultrasound exam uses sound waves to map the thyroid and the lymph nodes in your neck. It is the workhorse test here, and it is often repeated.
• A fine-needle aspiration biopsy takes cells through a thin needle, usually in a clinic room with ultrasound guiding it. Most people find it far less unpleasant than they feared.
• Blood hormone studies check how the gland is working, which is separate from whether it holds a cancer.
• A laryngoscopy is a look at the voice box to check that your vocal cords are moving normally. This is done because the nerve controlling them runs right beside the thyroid, so surgeons want a baseline first.

If your type is medullary thyroid cancer, genetics enters early. The NCI notes that a change in the RET gene passed from parent to child can cause it, and links it to familial medullary thyroid cancer and to multiple endocrine neoplasia type 2A. Ask for a genetics referral before surgery, not after, and ask whether your other hormone glands should be checked first. Ask too whether your relatives should be tested, because the NCI notes that family members found to carry the gene change may be offered surgery to lower their own risk.

For papillary and follicular cancer, the early fork is between a lobectomy and a total thyroidectomy. A lobectomy removes one half of the gland. A thyroidectomy removes all of it. Both are listed by the NCI as standard options.

That choice drives what follows. If half the gland stays, you may not need thyroid hormone tablets at all. If the whole gland goes, you will take hormone therapy for life to replace what the gland made.

There is a third path that surprises people. The NCI lists observation, sometimes called watchful waiting, among the standard approaches. For some very small, low-risk papillary cancers, careful monitoring with ultrasound is a legitimate plan rather than a delay. If that is offered to you, it is not your team taking your diagnosis lightly.

Radioactive iodine is also on the NCI's list, but it is not automatic. It is a treatment thyroid tissue absorbs, so it works for papillary and follicular disease. It does not work the same way for medullary or anaplastic thyroid cancer. If someone tells you that everyone with thyroid cancer gets it, that is not right.

• An endocrinologist, a doctor who specializes in hormone glands. For most people this is the doctor who runs long-term care.
• A thyroid or head and neck surgeon who does a high volume of these operations. Ask directly how many they do a year.
• A nuclear medicine specialist, if radioactive iodine is planned.
• A genetic counselor, if the type is medullary.
• A medical oncologist, mainly for advanced or anaplastic disease.

Ask about outlook, and you will find figures quickly. They need reading with care.

SEER, the federal cancer statistics program, reports that five-year relative survival for thyroid cancer is 98.3%, based on people diagnosed between 2016 and 2022. SEER also states that 63% of cases are found while still local, and that five-year relative survival for localized thyroid cancer is 99.9%.

Two honest warnings come with that. SEER itself says survival statistics "are based on large groups of people" and so "cannot be used to predict exactly what will happen to an individual patient." And that headline figure is an average across all four types, dominated by the common, slow-growing ones. It does not describe anaplastic thyroid cancer, which is a far more serious illness. If your type is anaplastic or advanced medullary, ask your own team for figures that match your disease rather than borrowing the overall number.

• National Cancer Institute — Thyroid Cancer Treatment (PDQ) Patient Version
• NCI SEER — Cancer Stat Facts: Thyroid Cancer